 |
|
|
| |
Baseline characteristics in JUNGLE, a German observational cohort study of Juluca as 2-Drug Regimen in virologically suppressed patients, compared to the phase-3 SWORD 1 & 2 study populations
|
| |
| |
17th European AIDS Conference, November 6-9, 2019, Basel
Reported by Jules Levin
Schabaz Farhad1, Wyen Christoph2, Postel Nils3, Pauli Ramona4, Seidel Thomas5, Weinberg Gordon6, Scholten Stefan7, Dymek Kathrin Maria8, Westermayer Bernd9, Scherzer Jenny8, Walli Ravi-K8
1 MVZ Karlsplatz, Munich, 2 Praxis Ebertplatz, Cologne, 3 prinzmed, Munich, 4 Isarpraxis, Munich, 5 MEDCENTER, Weimar, 6 Infektiologisches Zentrum, Steglitz, Berlin, 7 Praxis Hohenstaufenring, Cologne, 8 ViiV Healthcare, Munich, 9 GlaxoSmithKline, Munich
References
1 Llibre JM, Hung CC, Brinson C, et al. Lancet. 2018 Mar 3;391(10123):839-849.
|
| |
|
|
|
|
|
